Clinical trial
Donor Stem Cell Transplant in Treating Patients With Myeloid Cancer or Other…
NCT00392782 · Masonic Cancer Center, University of Minnesota, Other · Terminated
Key facts
| NCT number | NCT00392782 |
|---|---|
| Title | Donor Stem Cell Transplant in Treating Patients With Myeloid Cancer or Other Disease |
| Official title | A Multicenter, Prospective Trial to Evaluate the Role of NK Cell KIR Epitope Mismatch on Mortality and Disease Relapse in T-Cell Depleted Hematopoietic Stem Cell Transplantation From HLA-C Mismatched, Unrelated Donors for Myeloid Malignancies |
| Lead sponsor | Masonic Cancer Center, University of Minnesota, Other |
| Collaborators | Center for International Blood and Marrow Transplant Research |
| Status | Terminated |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Leukemia, Myelodysplastic Syndromes |
| Intervention type | Biological, Drug, Procedure, Radiation |
| Interventions | anti-thymocyte globulin, fludarabine phosphate, thiotepa, peripheral blood stem cell transplantation, total-body irradiation |
| Enrollment | 24 |
| Start date | Jul 1, 2005 |
| Primary completion | May 1, 2011 |
| Completion | May 1, 2011 |
| First posted | Oct 26, 2006 |
| Last update posted | Dec 28, 2017 |
| Countries | United States |
At a glance
- 1–9 Study sites
- Yes Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: